Lifeward Ltd. current report, 09 August 2021

Business Context and Reporting Period

This Form 8-K is a current report filed by ReWalk Robotics Ltd. (trading symbol: RWLK) on August 9, 2021. The filing announces the company's financial results for the second quarter of 2021, which ended on June 30, 2021. The company is incorporated in Israel and lists its ordinary shares on the Nasdaq Capital Market.

Key Financial Metrics

The provided text serves as a notification of the results and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the source text.

Material Changes

The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of a press release containing the Q2 2021 results.

Guidance, Outlook, and Management Commentary

  • Conference Call: Management scheduled a conference call for August 9, 2021, at 8:30 a.m. E.D.T. to discuss the financial results.
  • Availability: An archived webcast of the call was made available on the company's website and a third-party media server for 30 days following the event.
  • Legal Disclaimer: The information in this 8-K and the accompanying press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.

Investor Verification Checklist

  • Verify the specific revenue and net loss figures in the full Q2 2021 press release (Exhibit 99.1) referenced in this filing.
  • Review the archived conference call webcast for management's commentary on operational progress and future outlook.
  • Confirm the company's cash position and burn rate, as these are critical for a pre-revenue or early-stage medical device company but are not detailed in this summary text.
  • Check for any updates on regulatory approvals or product commercialization milestones discussed during the conference call.